SYS ONLINE
SUPPLEMENT_SCHOLAR
evidence · mechanism · dose
Experimental/NootropicResearch peptide

N-Acetyl Semax

aka NA-Semax · Acetylated Semax

Acetylated Semax variant with extended half-life and stronger BDNF effects.

Educational explainer of a research peptide. Profiles in this section deliberately omit clinical-trial citations, dosing protocols, and purchase links. Not FDA-approved as a supplement; not a recommendation to use.

Overview

An N-acetylated derivative of Semax with greater resistance to peptidase degradation and a longer duration of central action.

Source
  • Synthesized in research settings
Forms
  • Intranasal
  • Subcutaneous

Mechanism of action

Acts on the melanocortin system and elevates central BDNF and NGF, with effects on dopamine and serotonin neurotransmission.

Pathways
  • · Melanocortin (MC4R)
  • · BDNF / NGF induction
  • · Dopaminergic modulation
Neurotransmitters
  • · Dopamine
  • · Serotonin
  • · Acetylcholine

How it acts on the body

Acetylation stabilizes the N-terminus against aminopeptidases, increasing residence time and giving stronger and longer-lasting central effects than standard Semax. Users typically report sharper focus and mood elevation that lasts most of a day from a morning dose.

Mechanistically the peptide raises BDNF and NGF in the hippocampus and cortex, and shifts monoaminergic tone toward dopaminergic and serotonergic activity. Most evidence is Russian preclinical and small clinical work.

Hormonal & endocrine impact

How this peptide is reported to shift specific hormones and signaling molecules. Directionality reflects research literature and preclinical models, not clinical prescribing data.

Projected hormonal trajectory
Illustrative curves derived from reported direction of effect. Not measured patient data.

Curves are schematic shapes (sigmoid for increases/decreases, damped oscillation for modulation/stabilization) anchored to a 100% baseline. They communicate direction and tempo of change reported in research literature — not absolute hormone concentrations.

BDNF / NGFIncreases
Central neurotrophin elevation, sustained vs. plain Semax.
Dopamine toneModulates
Indirect, via metabolic and melanocortin pathways.
Cortisol responseDecreases
Stress-buffering effect in animal models.

Effects on the body

Supports
Focus and working memory
Supports
Mood and stress resilience

Organ system effects

Brain & CNS

Cortex and hippocampus.

Endocrine

Modest HPA modulation.

Reported effects

Drawn from preclinical research, anecdote, and small-scale clinical observation. No evidence grades are assigned — most peptides on this page lack rigorous human trials.

  • Longer duration than plain Semax
  • Combined cognitive and mood effects

Potential side effects

Common
  • · Headache
  • · Insomnia if dosed late
Rare
  • · Irritability
Serious
  • · None well-documented in available literature

Drug interactions

Strong dopaminergic agents
Theoretical additive effect.
moderate

Pairing context

Often combined with
  • Choline source
    Supports cholinergic component of cognitive effect.
Avoid combining with
  • Acute mania or psychosis
    Monoaminergic potentiation may worsen.
Important. Research peptides described here are not FDA-approved supplements. Supplement Scholar does not endorse, recommend, or link to any source for purchase. Consult a qualified clinician before considering any peptide therapy.